1.	Phase III CTX/ADR/VCR Therapy Alone or with Radiotherapy Followed by VP-16/HMM or MTX/CF/VP-16/HMM for Small Cell Lung Cancer Phase: Phase III Type: Treatment Status: Closed Age: under 75 Sponsor: Protocol IDs: SEG-78LUN328
2.	Phase III Pilot Intensification with High-Dose ARA-C and Consolidation with MACHO (CTX/ADR/VCR/PRED/MTX/L-ASP) for Adult ALL Phase: Phase III Type: Treatment Status: Completed Age: 15 to 65 Sponsor: NCI Protocol IDs: EST-2483
3.	Phase III Chemotherapy with HMM and High-Dose vs Low-Dose CACP, with or without VIT-B6, for Stage III/IV Ovarian Cancer (Summary last modified 06/97) Phase: Phase III Type: Treatment Status: Closed Age: no age specified Sponsor: NCI Protocol IDs: EST-2879R
4.	Phase III CACP/CTX vs HMM for Residual, non-Measurable Stage III Ovarian Adenocarcinoma Responsive to Prior CACP/CTX Phase: Phase III Type: Treatment Status: Completed Age: no age specified Sponsor: NCI Protocol IDs: GOG-61
5.	Phase III Post-remission Therapy with High-Dose ARA-C/AMSA Consolidation with No Maintenance vs Maintenance with ARA-C/TG vs Bone Marrow Therapy for Adult ANLL Phase: Phase III Type: Treatment Status: Completed Age: 15 to 65 Sponsor: NCI Protocol IDs: EST-3483
6.	Phase III Chemotherapy with High-Dose ARA-C/AMSA and Low-Dose ARA-C for Maintenance vs No Maintenance Therapy for Adult ANLL Phase: Phase III Type: Treatment Status: Completed Age: 18 to physiologic 70 Sponsor: NCI Protocol IDs: EST-5483
7.	Phase III Vitamin Therapy with Pyridoxine for Resected Transitional Cell Tumors of the Bladder Phase: Phase III Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: EORTC-30781
8.	Phase III Randomized Comparison of Adjuvant Perioperative and Postoperative 5-FU by Continuous Infusion vs No Adjuvant Chemotherapy in Patients with Dukes Stages C1/C2 Adenocarcinoma of the Colon (Summary Last Modified 07/88) Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: Protocol IDs: MAOP-5186, NCI-V88-0345
9.	Phase III Adjuvant Therapy for Dukes' Stage C Adenocarcinoma of the Colon: Protracted Infusional 5-FU plus LEV vs Bolus 5-FU plus LEV (Summary Last Modified 03/91) Phase: Phase III Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: MAOP-5186A, NCI-V90-0196
10.	Phase III Randomized, Double-Blind Study of Multiple Vitamins at the Recommended Daily Allowance (RDA) vs Multiple Vitamins at the RDA plus High-Dose Vitamins A, B6, C, and E in Patients with Transitional Cell Carcinoma of the Bladder (Summary Last Modified 06/91) Phase: Phase III Type: Supportive care Status: Closed Age: any age Sponsor: Protocol IDs: WVU-11715, NCI-V91-0025
11.	Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer Phase: Phase III Type: Supportive care Status: Completed Age: Not specified Sponsor: NCI, Other Protocol IDs: CASE5Y03, P30CA043703, NCT00245050
12.	Pyridoxine and Topical Urea/Lactic Acid-Based Cream in Preventing Hand-Foot Syndrome in Patients Receiving Capecitabine for Breast Cancer or Other Cancer Phase: Phase III Type: Supportive care Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000464246, NCCTG-N05C5, ROCHE-NCCTG-N05C5, N05C5, NCT00296036
13.	Phase III Randomized Study of Pyridoxine Hydrochloride in Preventing Palmar-Plantar Erythrodysesthesia in Patients Receiving Capecitabine for Colorectal or Breast Cancer. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase III Type: Supportive care Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: CRCA-CCTC-CAPP-IT, EUDRACT-2004-000325-29, EU-20786, ISRCTN82842634, CCTC-CAPP-IT, CCLG-CAPP-IT, NCT00559858
14.	A Randomized Phase III Study of Vitamins B6 and B12 to Prevent Chemotherapy-Induced Neuropathy in Cancer Patients Phase: Phase III Type: Supportive care, Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: INST 0553C, NCI-2012-00946, NCT00659269
15.	Phase I/II Pilot Study of Intensive Consolidation with High-Dose ARA-C/AMSA After Induction with DNM/ARA-C/TG for ANLL in Adults Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 15 to 70 Sponsor: NCI Protocol IDs: EST-PB-482
16.	Phase II Chemotherapy with VP-16/PCB/HMM for Small Cell Carcinoma of the Lung Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: NCI-D78-053-161
17.	Phase II Pilot Study of High-Dose ARA-C plus AMSA in Adults with Acute Nonlymphocytic Leukemia Phase: Phase II Type: Treatment Status: Completed Age: 15 to 65 Sponsor: NCI Protocol IDs: EST-PC-482
18.	Phase II Chemotherapy with MITO/HMM/DAVA for Inoperable non-Small Cell Bronchogenic Carcinoma Phase: Phase II Type: Treatment Status: Closed Age: under 70 Sponsor: NCI Protocol IDs: EST-PD-580
19.	Phase II Master Protocol and Chemotherapy with VM-26/PRED Plus cis-Platinum or Hexamethylmelamine for Lymphoma Phase: Phase II Type: Treatment Status: Completed Age: 15 to 76 Sponsor: NCI Protocol IDs: EST-1478
20.	Phase I Study of Taxol/HMM in Patients with Refractory or Residual Ovarian Cancer Phase: Phase I Type: Supportive care, Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: OSU-92HO043, NCI-T92-0014D, T92-0014